Bone Metastasis Model Development in an Immunocompetent Murine Host
Alexander H. Jinnah MD, Daniel N. Bracey MD PhD, Thomas L. Smith PhD, Bethany A. Kerr PhD
December 9, 2017
Bone Metastasis Model Development in an Immunocompetent Murine Host - - PowerPoint PPT Presentation
Bone Metastasis Model Development in an Immunocompetent Murine Host December 9, 2017 Alexander H. Jinnah MD, Daniel N. Bracey MD PhD, Thomas L. Smith PhD, Bethany A. Kerr PhD Background Prevalence of bone metastasis is 280,000 in US
Alexander H. Jinnah MD, Daniel N. Bracey MD PhD, Thomas L. Smith PhD, Bethany A. Kerr PhD
December 9, 2017
Wake Forest Baptist Medical Center
2
Li et al. 2012 Thibaudeau et al. 2014 Holen et al. 2015
Wake Forest Baptist Medical Center 3
Wake Forest Baptist Medical Center 4
Wake Forest Baptist Medical Center
5
Wake Forest Baptist Medical Center
6
Wake Forest Baptist Medical Center
7
Wake Forest Baptist Medical Center
8
Wake Forest Baptist Medical Center
9
Wake Forest Baptist Medical Center
Wake Forest Baptist Medical Center 11
Scaffold Monolayer 2 4 6 8 10 40 80
Control + Ascorbic
Gene Expression Relative to control Normalized to 18S
Wake Forest Baptist Medical Center 12
Wake Forest Baptist Medical Center 13
Wake Forest Baptist Medical Center
14
BMP-2
k 2 4 6 8 10 100 200
cells No cells
*
Gene Expression Relative to control Normalized to 18S
wnt3a
1 2 3 4 5 1000 2000
cells No cells
*
Gene Expression Relative to control Normalized to 18S
Wake Forest Baptist Medical Center 15
Trabecular Thickness
Scaffold Scaffold + OB 1 2 3 4 5
Pre Implantation Post Implantation Average Tb.Th Fold change
Wake Forest Baptist Medical Center 16
Wake Forest Baptist Medical Center
Wake Forest Baptist Medical Center 18
Wake Forest Baptist Medical Center 19